Kadimastem
Stem Cell Therapeutics for Diabetes and ALS
Active
Mature
Startup
Ness Ziona
Founded 2008-10
Kadimastem develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as amyotrophic lateral sclerosis (ALS) and diabetes. The technology has been developed as a platform enabling the manufacture of islet-like endocrine cells and glia-restricted progenitors. It has potenti…
SectorHealth Tech & Life Sciences
StageMature
Total raised$45.4M
Employees29
Founded2008-10
HQNess Ziona
Crunchbasekadimastem
Patents1
Confidence92
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals